Budget vs premium
SnagRx vs TMates: Which Costs Less Over 12 Months? (2026)
SnagRx or TMates? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.5 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
The choice between SnagRx and TMates usually comes down to one difference that neither homepage puts in its headline.
TMates costs 2.0x more per month than SnagRx once promotional pricing is out of the picture ($199/mo against $99/mo). Over a year that gap compounds into real money, and the question is what it buys.
Below, the two programs are set against the things that change the bill — the advertised rate, the rate after the promotion expires, the medication class and the inclusions. No number here is inferred; if a provider does not publish it, the table says so.
The short answer
- Lowest 12-month cost
- SnagRx — $828 against $2,388 at TMates, on each provider's own best published pricing.
- Most predictable bill
- SnagRx — Flat rate at every dose, so titration does not change what you are charged.
- Tirzepatide access
- SnagRx — Tirzepatide at $149/mo; the other side publishes semaglutide only.
- Easiest to pay for
- SnagRx — Neither publishes financing; both expect the full amount monthly.
SnagRx and TMates, side by side
This is the whole comparison in one screen. The sections underneath explain which of these rows should decide it.
| SnagRx | TMates | |
|---|---|---|
| Advertised price | Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan | $199/mo at every dose, no step-up fees |
| Rate after promotions | $99/mo | $199/mo |
| Pricing structure | Flat rate at every dose | Flat rate at every dose |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide |
| Price transparency | Published upfront | Published upfront |
| Tirzepatide | $149/mo | Not published |
| Support model | No coaching program stated | Provider check-ins included |
| Shipping | Free next-day UPS or FedEx in temperature-controlled packaging | Medication formulated in U.S. facilities |
| Patient reviews | 9,860 | 21,970 |
| eRxDoctor score | 7.5/10 | 7.0/10 |
What SnagRx and TMates actually cost over a year
The cheapest first month and the cheapest year are frequently different providers. The totals below are the honest version, built from the rates each provider publishes.
| SnagRx | TMates | |
|---|---|---|
| First month | $99 | $199 |
| Months 2 onward | $99/mo | $199/mo |
| 6-month total | $594 | $1,194 |
| 12-month total | $1,188 | $2,388 |
| Best published plan | 12-month semaglutide plan at $69/mo ($828 a year) — $828/yr | No multi-month discount published |
SnagRx finishes the year $1,560 cheaper. For some patients the support TMates bundles closes that gap; for a patient who only needs the prescription written, it does not.
Is TMates worth the premium?
The gap runs to 2.0x a month. What TMates offers for it: 24/7 access to U.S.-based doctors, not just messaging, plus medication formulated in U.S. facilities.
SnagRx's answer is the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly. What it does not carry: the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149.
For a patient who has taken a GLP-1 before, knows how they titrate and needs a reliable monthly refill, the cheaper program is usually the correct one and the premium is a donation. For a first prescription, the calculus changes.
SnagRx: what you are buying
SnagRx offers compounded semaglutide from $69/month and tirzepatide from $119/month, with the rate locked flat at every dose, named US 503A pharmacies and next-day shipping. What it is really selling here is the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly.
Practically: 5-minute intake, clinician review typically within 5 hours and always within 24, free next-day UPS or FedEx in temperature-controlled packaging, and a pricing model that is flat rate at every dose.
Ongoing care is 1:1 nursing staff plus a secure patient portal for refills and dose changes, and the medication list runs to compounded semaglutide and compounded tirzepatide.
SnagRx pros
- Bottom-of-market pricing on the annual plan: $69/mo semaglutide, $119/mo tirzepatide
- Price locked flat at every dose and at renewal — no re-pricing during titration
- Names its four US 503A partner pharmacies and its clinician network (OpenLoop Health)
- States LegitScript certification, which patients can verify independently
SnagRx cons
- Compounded medication only, no branded Ozempic, Wegovy, Mounjaro, or Zepbound
- The advertised $69 and $119 rates require the 12-month plan; month-to-month is $99 and $149
- Heavy urgency marketing, including a countdown timer on the pricing page
Where it gives ground to TMates: the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149.
A closer look at TMates
$199/month, every dose, no step-up fees In this pairing, its distinguishing feature is one flat $199 that survives every titration step, with doctors rather than a message queue behind it.
From signup to first shipment: virtual check-in appointments, then medication formulated in U.S. facilities. Billing follows a flat rate at every dose structure.
Support: 24/7 access to U.S.-based doctors, not just messaging. The medications on offer are compounded semaglutide.
TMates pros
- Virtual check-in appointments for ongoing medical oversight
- 24/7 access to U.S.-based doctors, not just messaging support
- Flat $199/month at every dose, no step-up fees as dosage escalates
- Medications formulated in U.S.-based facilities
TMates cons
- $199/month is higher than the cheapest compounded options
- Compounded semaglutide only, limited public detail on tirzepatide availability
- No branded Ozempic, Wegovy, or Zepbound
Set beside SnagRx, the thing to weigh: semaglutide only, and $199 is well above the cheapest compounded options.
Which one fits which patient
Choose SnagRx if:
- you are willing to commit for a term in exchange for a lower effective rate (12-month semaglutide plan at $69/mo ($828 a year))
- you want tirzepatide available without changing provider later
- you want the price you sign up at to survive titration
- the monthly rate is the constraint — $99/mo against $199/mo
Choose TMates if:
- you want to start on their timeline: virtual check-in appointments
- delivery works the way you want it to: medication formulated in U.S. facilities
- you want the price you sign up at to survive titration
- you are in a state where GLP-1 telehealth coverage is patchy
The compromises on both sides
On price. SnagRx is the cheaper program at $99/mo against $199/mo. What SnagRx gives up for that is the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149; what TMates charges for is one flat $199 that survives every titration step, with doctors rather than a message queue behind it.
On commitment. SnagRx rewards a longer commitment (12-month semaglutide plan at $69/mo ($828 a year)), which lowers the effective rate but ties up money before you know how you respond to the medication. Neither publishes financing options, so plan for the full amount each month.
On clinical contact. The support models differ — 1:1 nursing staff plus a secure patient portal for refills and dose changes against 24/7 access to U.S.-based doctors, not just messaging — and that difference is felt in week two, not week one.
On medication. SnagRx covers compounded semaglutide and compounded tirzepatide; TMates covers compounded semaglutide. Only SnagRx publishes a tirzepatide route, which matters if semaglutide underdelivers.
Evidence and regulatory status
It is worth separating the program from the pharmacology. What follows is true of the medication regardless of which of these two writes the prescription.
Cardiovascular benefit has been demonstrated for semaglutide in a specific population: adults with overweight or obesity and existing cardiovascular disease but no diabetes, per NEJM, SELECT.
In SURMOUNT-4, stopping tirzepatide after a lead-in period produced significant weight regain, where staying on it did not, per JAMA, SURMOUNT-4.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
SnagRx vs TMates: common questions
Is SnagRx cheaper than TMates?
Yes, on the ongoing rate. SnagRx runs $99/mo once promotional pricing ends, against $199/mo at TMates — a difference of 2.0x. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
Which has more patient reviews, SnagRx or TMates?
TMates, with 21,970 against 9,860. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Do SnagRx or TMates take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Do SnagRx and TMates prescribe the same medication?
Both dispense compounded GLP-1 preparations. SnagRx lists compounded semaglutide and compounded tirzepatide and TMates lists compounded semaglutide, so the molecules overlap even where the formulary does not match exactly.
Does SnagRx or TMates offer tirzepatide?
SnagRx does, at $149/mo. TMates publishes compounded semaglutide only, so moving to tirzepatide would mean moving provider — a new intake, a new price, and the loss of any rate you had locked in.
The verdict
SnagRx is the cheaper year by $1,560, and for a straightforward course of treatment that settles it.
The case for TMates is one flat $199 that survives every titration step, with doctors rather than a message queue behind it. That is worth $130 a month to some patients and nothing at all to others — be honest about which you are.
The failure mode here is not picking the wrong platform; it is stopping treatment because the bill moved. Choose the one whose bill you can predict.
Keep comparing
- SnagRx vs MaximusTirzepatide access
- SnagRx vs He & She MDBudget vs premium
- TMates vs MaximusBudget vs premium
- Mochi Health vs TMatesBudget vs premium
- Measured vs LIV BodyBudget vs premium
- Measured vs Start WillowBudget vs premium
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by SnagRx or TMates, and does not sell treatment. Read our ranking methodology.